OUR PRODUCTS

MOBILE APPS

GENERAL INFO

LCTX

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Lineage Cell Therapeutics (LCTX) Earnings Date & Reports

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LCTX is expected to report earnings to rise 35.50% to -2 cents per share on August 12

Lineage Cell Therapeutics LCTX Stock Earnings Reports

Q2'25

Est.

$-0.03

Q1'25

Beat

by $0.01

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.02

The last earnings report on May 13 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 195.97K shares outstanding, the current market capitalization sits at 224.79M.

View a ticker or compare two or three

Compare

LCTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For LCTX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LCTX showed earnings on May 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, and neurological conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2173 Salk Avenue

Phone

+1 442 287-8990

Employees

Web

https://www.lineagecell.com